Psoriasis (PsO)

Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis

Psoriasis Comorbidities at Hospital Calderón Guardia

Costa Rican Registry of IL-23 Inhibitors in Psoriatic Disease

Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease

Shared Pathways Between Non-Alcoholic Fatty Liver Disease and Psoriatic Disease With Guselekumab Therapy

Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis

The Effects of Audio-Based Therapy on Anxiety in Psoriasis

Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in Canada

Research on the Extraction of Tongue and Facial Diagnosis Features of Psoriasis Vulgaris in Traditional Chinese Medicine and Its Correlation With Laboratory Indicators

Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis

Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

A Trial of Academic Detailing to Promote Prescribing of Biosimilars

A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults

A Drug-Drug Interaction Study Between HS-10374 Tablets and Drospirenone and Ethinyl Estradiol Tablets(Yasmin®)

A Phase 2 Study of HB0017 in Psoriasis Patients

Microbiome and Clinical Response to Probiotics and Methotrexate in Early Psoriasis: a Pilot Study

Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis

Molecular Inflammation Board at the Center for Personalized Medicine

SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)

A Study to Assess Deucravacitinib Safety in Pregnancy